Blueprint Medicines Stock Predictions

Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.

Sell

BPMC
Blueprint Medicines

Last Price:

$101.69

Seasonality Move:

10.71%

7 Day Trial

ALL ACCESS PASS

$ 7

Top investors are buying this "unlisted" stock

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.

Blueprint Medicines Stock Forecast

Over the next 52 weeks, Blueprint Medicines has on average historically risen by 37.7% based on the past 10 years of stock performance.
Blueprint Medicines has risen higher in 4 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
Is Blueprint Medicines Stock Undervalued?

The current Blueprint Medicines [BPMC] share price is $101.69. The Score for BPMC is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
BPMC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Blueprint Medicines Stock Go Up Next Year?

Over the next 52 weeks, Blueprint Medicines has on average historically risen by 37.7% based on the past 10 years of stock performance.

Blueprint Medicines Stock Rating

Sell

Blueprint Medicines (BPMC) is a Sell

Is Blueprint Medicines overpriced?

Blueprint Medicines has risen higher in 4 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%

Blueprint Medicines Stock Price History

Is BPMC stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

blueprintmedicines.com

52-Week Data

52-Week High:

121.90

52-Week Low:

73.04

Prediction Charts

Market Cap:

6.6B

Price in USD:

101.69

Volume:

581.7K

Beta:

0.94

Technical Analysis

SMA50:

89.99

SMA100:

94.52

SMA200:

93.55

52-Wk Change:

-4.64%

Stock Predictions

Is Blueprint Medicines stock public?

Yes, Blueprint Medicines is a publicly traded company.
What is the Blueprint Medicines stock quote today?

The Blueprint Medicines stock price is 101.69 USD today.
How to buy Blueprint Medicines stock online?

You can buy Blueprint Medicines shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Apr-29	88.04	88.48	89.56	87.55
Apr-30	88.21	89.50	89.99	87.03
May-1	91.14	99.25	99.78	90.02
May-2	99.25	104.64	104.86	98.60
May-5	104.53	101.84	104.78	100.31
May-6	100.75	99.16	103.63	99.01
May-7	99.36	99.80	101.35	98.46
May-8	99.13	98.76	101.17	97.91
May-9	100.04	97.17	101.34	97.08
May-12	97.65	100.31	101.97	97.40
May-13	100.43	99.41	100.52	98.50
May-14	99.46	97.51	100.38	97.49
May-15	97.72	99.49	100.05	97.02
May-16	100.05	101.69	102.18	99.38

Blueprint Medicines Earnings

Blueprint Medicines Earnings Report: Per Share Blueprint Medicines Earnings Q1 Q2 Q3 and Q4 last year and next year.

Blueprint Medicines Forecast Revenue Growth

Blueprint Medicines Stock Analysis: Historical quarterly revenues per share for Blueprint Medicines and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.67 per share, an increase next quarter of $0.33 per share, an increase this year of $0.60 per share, and an increase next year of $1.46 per share.

* Blueprint Medicines stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.